Cybin (HELP) Change in Intangibles (2020 - 2024)
Cybin (HELP) posted quarterly Change in Intangibles of -$173280.3 for Q2 2024, down 258.1% year-on-year from $109604.8 in Q3 2023, and down 48.37% on a QoQ basis from -$116791.1 in Q4 2023.
Cybin (HELP) Change in Intangibles (2020 - 2024) Analysis & Trends
Cybin (HELP) has reported Change in Intangibles for 5 consecutive years, with -$173280.3 the latest figure, recorded in Q2 2024.
- Quarterly Change in Intangibles fell 258.1% year-over-year to -$173280.3 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$530910.9 (up 77.57% YoY) and the FY2021 annual result came in at -$72686.1, changed N/A from the prior year.
- Change in Intangibles eased to -$173280.3 in Q2 2024 per HELP's latest filing, from -$116791.1 in the prior quarter.
- Over the last five years, Change in Intangibles for HELP reached as high as -$5369.4 in Q4 2020 and fell as low as -$2.1 million in Q3 2022.
- A 5-year average of -$277861.3 and a median of -$114240.4 in 2021 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2022 — Change in Intangibles slumped 3754.95% — and 2023, when it soared 90.62%.
- Year by year, Change in Intangibles stood at -$5369.4 in 2020, then tumbled by 2027.63% to -$114240.4 in 2021, then sank by 33.49% to -$152497.5 in 2022, then increased by 23.41% to -$116791.1 in 2023, then sank by 48.37% to -$173280.3 in 2024.
- According to Business Quant data, Change in Intangibles over the past three periods registered -$173280.3, -$116791.1, and -$192450.1 for Q2 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -66,508.31 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -173,280.31 |
| Jun 30, 2024 | -173,280.31 |
| Dec 31, 2023 | -116,791.15 |
| Dec 31, 2023 | -116,791.15 |
| Sep 30, 2023 | -192,450.06 |
| Sep 30, 2023 | -192,450.06 |
| Jun 30, 2023 | -48,389.41 |
| Jun 30, 2023 | -48,389.41 |
| Dec 31, 2022 | -152,497.51 |
| Dec 31, 2022 | -152,497.51 |
| Sep 30, 2022 | -2.05 Mn |
| Sep 30, 2022 | -2.05 Mn |
| Dec 31, 2021 | -114,240.40 |
| Dec 31, 2021 | -114,240.40 |
| Sep 30, 2021 | -53,225.42 |
| Sep 30, 2021 | -53,225.42 |
| Jun 30, 2021 | -78,098.61 |
| Jun 30, 2021 | -78,098.61 |
| Mar 31, 2021 | -70,318.82 |
| Mar 31, 2021 | -70,318.82 |